FDA cannot receive a submission until all applicable requirements, including user
fee obligations, are satisfied. If FDA refuses to receive a submission for failure to
pay fees or because a sponsor or its affiliate is on the arrears list, FDA will set the
new submission receipt date to the date that the final user fee obligation is satisfied,
unless FDA finds that refusal to receive is appropriate for reasons not related to
fees.